Literature DB >> 17912931

Source apportionment of fine particulate matter in the southeastern United States.

Sangil Lee1, Armistead G Russell, Karsten Baumann.   

Abstract

Particulate matter (PM) less than 2.5 microm in size (PM2.5) source apportionment by chemical mass balance receptor modeling was performed to enhance regional characterization of source impacts in the southeastern United States. Secondary particles, such as NH4HSO4, (NH4)2SO4, NH4NO3, and secondary organic carbon (OC) (SOC), formed by atmospheric photochemical reactions, contribute the majority (>50%) of ambient PM2.5 with strong seasonality. Source apportionment results indicate that motor vehicle and biomass burning are the two main primary sources in the southeast, showing relatively more motor vehicle source impacts rather than biomass burning source impacts in populated urban areas and vice versa in less urbanized areas. Spatial distributions of primary source impacts show that each primary source has distinctively different spatial source impacts. Results also find impacts from shipping activities along the coast. Spatiotemporal correlations indicate that secondary particles are more regionally distributed, as are biomass burning and dust, whereas impacts of other primary sources are more local.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17912931     DOI: 10.3155/1047-3289.57.9.1123

Source DB:  PubMed          Journal:  J Air Waste Manag Assoc        ISSN: 1096-2247            Impact factor:   2.235


  2 in total

1.  Statistical evaluation of the feasibility of satellite-retrieved cloud parameters as indicators of PM2.5 levels.

Authors:  Chao Yu; Larry Di Girolamo; Liangfu Chen; Xueying Zhang; Yang Liu
Journal:  J Expo Sci Environ Epidemiol       Date:  2014-07-23       Impact factor: 5.563

2.  Association Between Health Symptoms and Particulate Matter from Traffic and Residential Heating - Results from RHINE III in Tartu.

Authors:  Mihkel Pindus; Hans Orru; Marek Maasikmets; Marko Kaasik; Rain Jõgi
Journal:  Open Respir Med J       Date:  2016-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.